Fig. 3From: Analysis of gene expression levels and their impact on survival in 31 cancer-types patients identifies novel prognostic markers and suggests unexplored immunotherapy treatment options in a wide range of malignanciesGene expression levels of the 9 ICRs in primary (N = 104) and metastatic (N = 368) melanoma patientsBack to article page